Organisation paid for research Program year 2025 Source: CMS Open Payments

Florida Eye Associates, Inc

Neither a doctor nor a teaching hospital

Research payments

$1,157,410

94 payments

Through program year 2025, Florida Eye Associates, Inc is reported as receiving $1,157,410 in research payments, across 94 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$117,689	12
2024	Research	$96,284	16
2023	Research	$712,322	54
2022	Research	$231,115	12

Breakdown

Who paid Research payments · program years 2022–2025

Roche TCRC, Inc. $721,817 35 payments
Genentech, Inc. $435,594 59 payments

Studies the money was for Research payments · program years 2022–2025

Ro7200394 for Namd $266,764 10 payments
Phase 2 Study of Anti Il6 Mab With RBZ in Combination in Patients With Dme $256,707 8 payments
Open Label Extension Study to Evaluate the Long Term Safety of Faricimab in Patients With Namd $170,562 9 payments
Entry Into Human of Ro7497372 in Participants With Diabetic MacUlar Edema $99,468 9 payments
Port Delivery System of Ranibizumab Extension Study $92,696 15 payments
Phase 2 Study to Investigate Ro7200220 in Diabetic MacUlar Edema $52,300 1 payment
Faricimab Dme Long Term Extension Rhone X $50,674 8 payments
Oral Treatment of NPDR $36,516 5 payments
A Phase III Study to Evaluate Faricimab in Patients With Central Retinal Vein Occlusion $34,989 6 payments
PH 2 Open Label Extension of Ahtra1 in Ga $34,067 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.